PYROXD1
protein-codingpyridine nucleotide-disulphide oxidoreductase domain 1
Gene summary
This gene encodes a nuclear-cytoplasmic pyridine nucleotide-disulphide reductase (PNDR). PNDRs are flavoproteins that catalyze the pyridine nucleotide-dependent reduction of thiol residues in other proteins. The encoded protein belongs to the class I pyridine nucleotide-disulphide oxidoreductase family but lacks the C-terminal dimerization domain found in other family members and instead has a C-terminal nitrile reductase domain. It localizes to the nucleus and to striated sarcomeric compartments. Naturally occurring mutations in this gene cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. A pseudogene of this gene has been defined on chromosome 11. [provided by RefSeq, Apr 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~33.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014993
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014993
Submitter: ClinGen
PYROXD1 was first reported in relation to autosomal recessive myofibrillar myopathy 8 in 2016 (O'Grady GL, et al., 2016, PMID: 27745833). At least 7 unique variants (including missense, frameshift, and intronic) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 12 probands in four publications (PMIDs: 27745833, 31455395, 30345904, 30515627). Variants in this gene segregated with disease in six additional family members. This gene-disease relationship is supported by a Zebrafish knockdown model which is rescued by expression of human PYROXD1 (PMID: 27745833). Of note, this gene has been implicated in 12 families to date with a progressive course of disease and a predominant involvement of upper and lower limb muscles, however some exhibit a LGMD-like phenotype with childhood or adulthood disease onset while others are affected at birth, or in infancy, and manifest a more severe and complex clinical picture including scoliosis, nasal speech, joint hypermobility, contractures, rigid spine, pectus excavatum, and anomalies of the feet and hands. Overall and in view of the histological characteristics on biopsies as cores, central nuclei, and sarcoplasmic aggregates, PYROXD1-related myopathy can be considered as mixture of core myopathy, centronuclear myopathy, and myofibrillar myopathy which here have all been lumped into one disease entity. In summary, PYROXD1 is definitively associated with autosomal recessive myofibrillar myopathy 8.
Inheritance Pattern: AR
Disease ID:MONDO:0014993
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014993
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014993
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Musculoskeletal
Intervention: Cardiovascular
Rationale: Though not common, some individuals can have cardiovascular manifestations, and awareness can allow medical management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PYROXD1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_024854.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 61 | 2 | 63 | |||
| missense | 2 | 1 | 151 | 10 | 164 | |
| nonsense | 2 | 1 | 3 | |||
| start loss | 0 | |||||
| frameshift | 8 | 6 | 1 | 15 | ||
| splice donor/acceptor (+/-2bp) | 2 | 10 | 5 | 17 | ||
| Total | 14 | 17 | 158 | 71 | 2 | 262 |
Highest pathogenic variant AF is 0.00019409128
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_079130.2 | 12 | MANE Select | |
| Ensembl | ENSP00000240651.9 | 12 | MANE Select | |
| RefSeq | NP_001337841.1 | 10 | Standard | |
| RefSeq | NP_001337842.1 | 5 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| pyroxd1 | Danio rerio | Structure: skeletal muscle Quality: broken abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- cellular response to oxidative stress
- oxidation-reduction process
Molecular Function
- protein binding
- oxidoreductase activity
Cellular Component
- nucleus
- sarcomere
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000240651
- Coding exons
- 12
- Length
- 32752
- Individuals with no LoFs
- 125670
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 78
- Defined
- 125748
- p
- 0.000310
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0969 | 252 | 256 | 0.983 | 0.0000123 | 3285 |
| Missense (PolyPhen) | 60 | 78.034 | 0.7689 | 989 | ||
| Synonymous | 0.0292 | 91 | 91.4 | 0.996 | 0.00000476 | 907 |
| Loss of Function | 1.69 | 17 | 26.4 | 0.644 | 0.00000140 | 345 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00049 | rare |
| Latino/Admixed American | 0.00045 | 0.00040 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.00037 | 0.00035 | rare |
| South Asian | 0.00028 | 0.00026 | rare |
| Other | 0.00050 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in cellular response to oxidative stress. {ECO:0000269|PubMed:27745833}.;
- Disease
- DISEASE: Myopathy, myofibrillar, 8 (MFM8) [MIM:617258]: A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM8 is an autosomal recessive form, clinically characterized by slowly progressive symmetrical weakness affecting both proximal and distal muscles, with normal to moderately elevated creatine kinase. Mild facial weakness, a high palate, nasal speech, and swallowing difficulties are typical features, mild restrictive lung disease is common, and late-onset cardiac involvement may be present. {ECO:0000269|PubMed:27745833}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0932
Intolerance Scores
- LoFtool
- 0.499
- RVIS EVS
- -0.53
- RVIS percentile EVS
- 20.7
Essentials
- Essential (CRISPR)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.712
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |